MHRA approves first new UTI antibiotic in 30 years

An oral antibiotic for urinary tract infections (UTIs) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA), marking the first new UTI antibiotic for 30 years. Gepotidacin (Blujepa; GSK) is a new type of antibiotic, which involves a triazaacenaphthylene that inhibits two type II topoisomerase enzymes, in what GSK said is a […]

Publication Details

Journal: Pharmaceutical journal/The pharmaceutical journal
Published: 2025-01-01
DOI: https://doi.org/10.1211/pj.2025.1.371433
Primary Topic: Science, Research, and Medicine
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

MHRA approves first new UTI antibiotic in 30 years

Jan 1, 2025

Pharmaceutical journal/The pharmaceutical journal

Science, Research, and Medicine

article

MHRA approves first new UTI antibiotic in 30 years

January 1, 2025article en

Abstract

Pharmaceutical journal/The pharmaceutical journal

Openalex Percentile: Top 70%

Science, Research, and Medicine

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

MHRA approves first new UTI antibiotic in 30 years · Pharmaceutical journal/The pharmaceutical journal (2025) | TGRS Research Map | TGRS